Drugs Made In America Acquisiti
DMII
Last
$10.20
Day
+0.1%
1y
+3.1%
5y
+3.1%
52w
-1.4%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
10.17
EMA 50
10.15
EMA 200
10.05
20d high
-1.4%
5y high
-1.4%
5y range
70th
Positions held
Your positionsDMII isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
35
Hold
swing
Signal
Strong Buy
Target
$10.25
Stop
$10.16
Stop distance
0.4%
Target vs last
+0.5%
Fundamentals
| Market cap | $649.10M | Enterprise value | $649.38M | Trailing P/E | 33.97 | Forward P/E | — |
| PEG | — | Price / book | -36.26 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.34 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $10.33 | 52w low | $9.86 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | $4.4M | $4.3M | $4.3M | -$0.0M | -$0.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$0.1M | -$0.1M | -$1.0M | -$0.2M | -$0.0M | — |
Yearly (6y)
| 2025 | |
|---|---|
| Revenue | $0.0M |
| Op margin | — |
| Net income | $4.2M |
| Gross margin | — |
| Gross profit | — |
| Operating income | -$1.3M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsDMII · daily+0.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin